🧭 Begeleide weergave Nieuw in de genetica? We leggen elk begrip uit terwijl je bladert, in gewone taal. Dezelfde pagina's, met de hulp ingebouwd.
⚡ Expertvisie Je kent de biologie al. Alleen de inhoud — helder en compact, zonder extra uitleg. Dit is de standaardweergave.
Interfacetaal
Lichte modus
Institution · Research institute
Innovative Genomics Institute
Founded by Jennifer Doudna at Berkeley to move genome editing into real applications — including ones that would never be commercially viable.
Eenvoudige uitleg
The Innovative Genomics Institute was set up by Jennifer Doudna to work on what CRISPR is actually for: treating disease, improving crops, and — unusually — doing it in ways that could reach people who cannot afford two-million-dollar medicines. It runs programmes explicitly aimed at affordability and at individual rare-disease patients.
Dieper ingaan
The Innovative Genomics Institute is a joint University of California, Berkeley and UC San Francisco research centre founded by Jennifer Doudna in 2014. Its work spans therapeutic editing, agricultural genomics, climate applications and public engagement, with an explicit programme on affordable and scalable editing therapies for rare disease.
Alleen educatieve informatie
Deze pagina is een naslagbron, geen medisch advies. Onderzoeks- en regelgevingsstatus veranderen; controleer de datum van de laatste update hierboven en verifieer belangrijke informatie bij de vermelde primaire bronnen.
